Ecolab (ECL)
(Delayed Data from NYSE)
$244.57 USD
-1.16 (-0.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$244.57 USD
-1.16 (-0.47%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Zacks News
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.
Intuitive Surgical (ISRG) Gets FDA Nod for da Vinci's New Label
by Zacks Equity Research
Intuitive Surgical (ISRG) announces the FDA clearance of revised da Vinci Xi and X Labeling on Radical Prostatectomy.
Celanese (CE) Down 8.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
B2Gold (BTG) Inks Deal With Sandbox to Sell 10 Royalties
by Zacks Equity Research
B2Gold (BTG) to sell 10 royalties to Sandbox to maximize the value of the royalties.
Andersons (ANDE) Signs Letter of Intent to Buy Skyland Interest
by Zacks Equity Research
Andersons (ANDE) plans ownership interest in Skyland to boost its portfolio.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
by Indrajit Bandyopadhyay
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
by Zacks Equity Research
Masimo's (MASI) R&D activities raise optimism about the stock.
Innospec (IOSP) & IJM Collaborate to Protect Palm Oil Workers
by Zacks Equity Research
Innospec (IOSP) partners with IJM to combat forced labor in the Southeast Asia palm oil sector.
Tronox (TROX) Inks Long-Term Power Purchase Deal With NOA
by Zacks Equity Research
The agreement is another example of Tronox's (TROX) ongoing projects and investments aimed at achieving its publicly stated objective of net zero greenhouse gas emissions by 2050.
What Makes L.B. Foster (FSTR) Stock a Solid Choice Right Now
by Zacks Equity Research
L.B. Foster (FSTR) offers a strong investment opportunity with stellar first-quarter earnings, promising growth prospects and solid operational performance set to continue through 2024.
Air Liquide (AIQUY) to Build Gas Facility for Chip Production
by Zacks Equity Research
Air Liquide (AIQUY) is investing $250 million in an Idaho gas facility to support Micron Technology's new semiconductor fab, enhancing U.S. supply chain resilience.
DexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
by Zacks Equity Research
DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States, the UK, and Ireland.
Cabot (CBT) Gets Operation Clean Sweep Europe Certification
by Zacks Equity Research
Cabot (CBT) is one of Europe's first black masterbatch manufacturers to receive this third-party certification.
Chemours (CC) Announces Enhancement of EVOLVE 2030 Methodology
by Zacks Equity Research
The revised EVOLVE 2030 approach improves Chemours' (CC) ability to integrate its business processes with this goal.
Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Stryker's (SYK) LIFEPAK 35 to Offer Advanced Monitoring System
by Zacks Equity Research
Stryker (SYK) announces the launch of LIFEPAK 35 monitor/defibrillator, which is likely to aid emergency responders to reduce cognitive load during demanding situations by improving workflow.
WestRock's (WRK) VPPA Project With ENGIE Becomes Operational
by Zacks Equity Research
WestRock's (WRK) first VPPA Project with ENGIE is now operational, marking a step forward to achieving 2030 science-based greenhouse gas targets.
Universal Stainless (USAP) Surges 48% in 3 Months: Here's Why
by Zacks Equity Research
Universal Stainless' (USAP) rally reflects a robust first-quarter performance on the back of record aerospace sales.
ArcelorMittal (MT) & Materialise Partner for Metal 3D Printing
by Zacks Equity Research
ArcelorMittal (MT) and Materialise join forces to enhance LPBF and metal 3D printing using advanced build processors and specialized steel powders.
PPG Achieves 40% Reduction in Overspray Using SIGMAGLIDE 2390
by Zacks Equity Research
PPG strongly believes in the long-term viability of electrostatic application and is promoting it in shipyards around Europe, Singapore and China.
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
by Zacks Equity Research
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
Stryker's (SYK) Acquisition of Artelon Set to Expand Its Market
by Zacks Equity Research
Stryker (SYK) announces the signing of the definitive agreement to acquire a privately held company, Artelon, to strengthen its foothold in the soft tissue fixation market.
Here's Why You Should Retain Nevro (NVRO) Stock for Now
by Zacks Equity Research
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
Nucor (NUE) Expands Portfolio With $565M Acquisition of Rytec
by Zacks Equity Research
Nucor (NUE) is acquiring Rytec Corporation for $565 million to expand its product portfolio and leverage cross-selling opportunities in the commercial doors market.
BASF (BASFY) Divests Bioenergy Enzymes Business to Lallemand
by Zacks Equity Research
BASF (BASFY) continues to concentrate on its enzyme activities in the animal feed and detergent sectors.